Skip to content
10-Q

Quarterly Report

CYCLO THERAPEUTICS, INC.

0001437749-24-026889

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 14, 2024 28.7M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$10.03M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$7.85M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $1.12M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $9.25M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$5.12M
Stockholders Equity Q2 2024 · Dec 31, 2023 $4.76M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$1.48M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$438.88K
Stockholders Equity Q2 2024 · Dec 31, 2022 $734.54K
Current Liabilities Q2 2024 · Jun 30, 2024 $9.83M
Current Liabilities Q2 2024 · Dec 31, 2023 $8.47M
Current Assets Q2 2024 · Jun 30, 2024 $4.45M
Current Assets Q2 2024 · Dec 31, 2023 $12.32M
Total Assets Q2 2024 · Jun 30, 2024 $4.72M
Total Assets Q2 2024 · Dec 31, 2023 $13.25M
Eps Basic Q2 2024 · Jun 30, 2024 −$0.21
Eps Basic Q2 2024 · Jun 30, 2024 −$0.36
Eps Basic Q2 2024 · Jun 30, 2023 −$0.33
Eps Basic Q2 2024 · Jun 30, 2023 −$0.77
Rd Expense Q2 2024 · Jun 30, 2024 $3.49M
Rd Expense Q2 2024 · Jun 30, 2024 $6.34M
Rd Expense Q2 2024 · Jun 30, 2023 $3.17M
Rd Expense Q2 2024 · Jun 30, 2023 $6.57M
Net Income Q2 2024 · Jun 30, 2024 −$5.98M
Net Income Q2 2024 · Jun 30, 2024 −$10.32M
Net Income Q2 2024 · Jun 30, 2023 −$4.64M
Net Income Q2 2024 · Jun 30, 2023 −$9.64M
Operating Income Q2 2024 · Jun 30, 2024 −$5.64M
Operating Income Q2 2024 · Jun 30, 2024 −$10.76M
Operating Income Q2 2024 · Jun 30, 2023 −$4.63M
Operating Income Q2 2024 · Jun 30, 2023 −$9.64M
Gross Profit Q2 2024 · Jun 30, 2024 $109.72K
Gross Profit Q2 2024 · Jun 30, 2024 $300.35K
Gross Profit Q2 2024 · Jun 30, 2023 $97.21K
Gross Profit Q2 2024 · Jun 30, 2023 $239.42K